The project seeks to develop materials explaining chemotherapy regimens for patients with biliary tract cancers and then translate these materials into “standardized, high-quality, free, and easily ...
Gallbladder cancer and cholangiocarcinoma are both biliary cancers. They can cause the same symptoms, but causes and treatments can differ. Gallbladder cancer is cancer of the gallbladder, while ...
Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...
Available to treat adults with locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement PEMAZYRE ® (pemigatinib) is available via a co-pay access program in Australia ...
Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...
The FDA approved a kinase inhibitor for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion or other arrangement. The Food ...
Ten years ago, Cholangiocarcinoma was a little known, little understood, rare disease, also known as an orphan cancer. This is no longer the case ever since the Cholangiocarcinoma Foundation was ...
BASKING RIDGE, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for ...
Each year, around 8,000 people in the United States receive a diagnosis of bile duct cancer. This means it’s a very rare cancer. Your liver produces bile to help you digest fats by turning them into ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback